Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages. by Bert Baumgaertner (3595814)

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

SEM images of the samples (a) virgin sample (b) 0.4 wt. % <i>f-MWCNTs</i> (c) 0.5 wt. % <i>f—MWCNTs</i>. by Shaban Gul (14309526)

Subjects:

HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity by Qin Huang (49441)

Subjects:

Decreased biofilm formation in the Δ<i>tad123</i> mutant cells. by Tra-My Duong-Nu (7300970)

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Subjects:

Preliminary search for price decreases for the period 01 Jan. 2021–14 Jun. 2022. by Jevgeni Tarassov (13889285)

Decrease in loss during the training process. by Muhammad Idrees (92773)

Decreased test sensitivity: Screening the whole population. by Timo de Wolff (9904467)

Stress-strain curves of different wt. % <i>f-MWCNTs</i> based modified GFRPs. by Shaban Gul (14309526)

Subjects:

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

“…(B) In the hippocampus, we observed decreased PrP^Res, GFAP and vacuolation in responder and non-responder mice compared to infected untreated mice. …”

The A1 mutation decreases antisense transcriptional activity of the LTR in OVK cells. by Thomas Joris (13224720)

Inhibition of PKC or Rho protein kinase decreases Ad5 wild type replication <i>in vitro</i>. by Alice Liu (4814415)

(a) Schematic of the sample preparation, (b) developed GFRPs samples modified, (c) samples for impact strength tests, (d) samples for compressive strength tests. by Shaban Gul (14309526)

Subjects:

XRD pattern of (a) virgin sample (b) 0.4 wt. % <i>f-MWCNTs</i> glass fiber composite. by Shaban Gul (14309526)

Subjects:

Functionalization reaction of the MWCNTs. by Shaban Gul (14309526)

Subjects:

FTIR analysis of the <i>f-MWCNTs</i> modified GFRPs composite containing 0.4 wt. % <i>f-MWCNTs</i>. by Shaban Gul (14309526)

Subjects: